Lentris
Prescription Required Why?
- Active ingredient Lenvatinib
-
Dispensing Country
India
Substitutes
Active Ingredient: Lenvatinib
Active Ingredient: Lenvatinib
Lentris (Lenvatinib) Product Description
Lentris, containing the active ingredient Lenvatinib, is a targeted therapy used primarily for the treatment of certain types of cancer, including differentiated thyroid cancer, hepatocellular carcinoma, and renal cell carcinoma. This medication works by inhibiting specific proteins that promote cancer cell growth and division.
Indications
Lentris is indicated for patients with:
- Differentiated thyroid cancer that is refractory to radioactive iodine treatment.
- Unresectable hepatocellular carcinoma.
- Advanced renal cell carcinoma in combination with other therapies.
Mechanism of Action
Lenvatinib functions as a tyrosine kinase inhibitor, targeting receptors involved in tumor growth and angiogenesis. By blocking these pathways, Lentris helps to slow down or stop the progression of cancer.
Dosage and Administration
The dosage of Lentris may vary based on the type of cancer being treated and the patient's overall health. It is typically taken orally, with or without food, at the same time each day. It is essential to follow the healthcare provider's instructions regarding dosage and duration of treatment.
Potential Side Effects
Common side effects of Lentris may include:
- Hypertension
- Fatigue
- Diarrhea
- Nausea
- Decreased appetite
Patients should report any severe or persistent side effects to their healthcare provider.
Precautions
Before starting Lentris, patients should inform their healthcare provider of any pre-existing conditions, particularly heart problems, liver disease, or high blood pressure. Regular monitoring of blood pressure and liver function tests may be required during treatment.
Drug Interactions
Lentris may interact with other medications. Patients should provide their healthcare provider with a complete list of medications, including over-the-counter drugs and supplements, to avoid potential interactions.
Conclusion
Lentris (Lenvatinib) is a powerful treatment option for specific cancers, offering a targeted approach to therapy. Patients should work closely with their healthcare team to ensure the best outcomes while managing any side effects or concerns during treatment.
